Skip to main content
. Author manuscript; available in PMC: 2021 Jan 10.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2019 Sep 14;96:109761. doi: 10.1016/j.pnpbp.2019.109761

Fig.3.

Fig.3.

Effects of Ly225.910 (0.1mg Kg−1) on the object-recognition (NOD) task. The figure portrays (a) the discrimination index in the two 5-min choice (1-object recognition and 2-location recognition) sessions and (b) the proportion of animals that failed to explore objects. The data are in mean ± SEM; * p < 0.05; ** p < 0.01 compared to no discrimination (One-sample t-test, N=11–15); # # # p < 0.001 compared to Ly225.910-treated group (Fisheŕs Exact Test, N=16).

HHS Vulnerability Disclosure